In a recent study published Monday in the Archives of Internal Medicine several authors propose a new way of monitoring drugs that could increase the margin of safety for consumers. Utilizing internal documents from the Vioxx litigation, Dr. Joseph S. Ross of the Mt. Sinai School of Medicine in New York and others set out a method of analyzing clinical studies and post-marketing surveillance data that showed had Merck utilized their method, the cardiovascular risk of Vioxx would have been known two years before Merck withdrew the drug from the US market.
At this time, the Locks Law Firm is open for business and is fully functional, despite the COVID-19 pandemic.
Most of our attorneys and staff members are working remotely and we are fully equipped to continue providing all services during this time of uncertainty. As each state's guidelines are updated, we will gradually be returning to work from our four offices. In the meantime, we would ask that you communicate with us by phone, email or fax and we will respond as quickly as possible. Please do not visit our offices at this time without first communicating with a staff member.